BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6174989)

  • 1. Polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex [poly(ICL)] without carboxymethylcellulose (CMC): a new primate-effective interferon inducer.
    Riley FL; Morin ML; Lvovsky E; Stephens EE; Levy HB
    Proc Soc Exp Biol Med; 1982 Feb; 169(2):183-8. PubMed ID: 6174989
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon induction in primates by stabilized polyriboinosinic acid-polyribocytidylic acid: effect of component size.
    Levy HB; Riley FL; Lvovsky E; Stephen EE
    Infect Immun; 1981 Nov; 34(2):416-21. PubMed ID: 6171519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex.
    Sammons ML; Stephen EL; Levy HB; Baron S; Hilmas DE
    Antimicrob Agents Chemother; 1977 Jan; 11(1):80-3. PubMed ID: 402107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates.
    Levy HB; Baer G; Baron S; Buckler CE; Gibbs CJ; Iadarola MJ; London WT; Rice J
    J Infect Dis; 1975 Oct; 132(4):434-9. PubMed ID: 810520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon induction in piglets with polyinosinic:polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
    Loewen KG; Derbyshire JB
    Res Vet Sci; 1988 Jan; 44(1):132-3. PubMed ID: 2453906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose.
    Stringfellow DA; Weed SD
    Antimicrob Agents Chemother; 1980 Jun; 17(6):988-92. PubMed ID: 6157363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics of interferon induction by poly ICLC in humans.
    Bever CT; McFarland HF; McFarlin DE; Levy HB
    J Interferon Res; 1988 Aug; 8(4):419-25. PubMed ID: 2459270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor response to interferon inducer and radiation effect of serum interferon levels.
    Lvovsky EA; D'Souza J; Eng D; D'Souza D; Lvovsky B; Hetland R; Craver WL; Sobel SH
    J Biol Regul Homeost Agents; 1988; 2(1):1-6. PubMed ID: 2459908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator.
    Peters CJ; Reynolds JA; Slone TW; Jones DE; Stephen EL
    Antiviral Res; 1986 Aug; 6(5):285-97. PubMed ID: 2429616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferon induction in monkeys by poly I-C complex with poly-L-lysine].
    Bektemirov TA; Burgasova MP; Andzhaparidze OG
    Vopr Virusol; 1976; (5):536-9. PubMed ID: 827121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of interferon responses to poly ICLC in males and females.
    Bever CT; McFarlin DE; Levy HB
    J Interferon Res; 1992 May; Spec No():85-90. PubMed ID: 1379290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal interferon induction in dogs, using a modified polyriboinosinic-polyribocytidylic acid complex.
    Smith JS; Yager PA; Baer GM
    Am J Vet Res; 1980 Nov; 41(11):1833-5. PubMed ID: 6163381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of hematopoietic stem cells by interferon inducer in nonhuman primates receiving fractionated total body irradiation.
    Lvovsky EA; Levine PH; Bengali Z; Leiseca SA; Cicmanec JL; Robinson JE; Bautro N; Levy HB; Scott RM
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1721-6. PubMed ID: 6759479
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of interferon responses to poly ICLC in males and females.
    Bever CT; McFarlin DE; Levy HB
    J Interferon Res; 1985; 5(3):423-8. PubMed ID: 2414373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Historical overview of the use of polynucleotides in cancer.
    Levy HB
    J Biol Response Mod; 1985 Oct; 4(5):475-80. PubMed ID: 2416882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of interferon in blood, cerebrospinal fluid, and brain after administration of modified polyriboinosinic-polyribocytidylic acid and amphotericin B.
    Williams BB; Paul RT; Lerner AM
    J Infect Dis; 1982 Dec; 146(6):819-25. PubMed ID: 6183371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of virus-induced murine diabetes by an interferon inducer.
    Gadzik JP; Naji A; Barker CF; Blank KJ
    J Interferon Res; 1982; 2(1):59-63. PubMed ID: 6286804
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhanced induction of plasma interferon after subcutaneous administration in rabbits of poly ICLC with albumin.
    Pessina GP; Muscettola M; Paulesu L; Bocci V
    J Biol Regul Homeost Agents; 1989; 3(3):118-21. PubMed ID: 2483023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified polyriboinosinic-polyribocytidylic acid complex: induction of serum interferon, fever, and hypotension in rabbits.
    Gatmaitan BG; Legaspi RC; Levy HB; Lerner AM
    Antimicrob Agents Chemother; 1980 Jan; 17(1):49-54. PubMed ID: 7352750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular alteration by interferon: a virus-free system for assaying interferon.
    Stewart WE; De Clercq E; De Somer P
    J Virol; 1972 Nov; 10(5):896-901. PubMed ID: 4344256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.